GlassScriptPhysician profile
Anthony M White
NPI 1386141521
$7,934.63
in general payments reported to CMS, 2019-2025
8 companies · $3,211 in 2025
The $3,211 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,864 · 2024: $860 · 2025: $3,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,107 · Food and Beverage: $3,689 · Education: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,106.67 |
| Food and Beverage | $3,689.46 |
| Education | $138.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,452.68 | 2023-2025 | Mako, Insignia, Triathlon |
| Conetic Solutions, INC. | $208.79 | 2024-2025 | |
| Smith+Nephew, INC. | $97.59 | 2024 | Real Intelligence |
| Zimmer Biomet Holdings, INC. | $93.85 | 2024 | Persona |
| Solventum Corporation | $22.99 | 2025 | V.A.C. Veraflo, Prevena |
| Djo, LLC | $21.13 | 2025 | Cmf |
| Endo USA, INC. | $20.72 | 2025 | Xiaflex |
| Heron Therapeutics, INC. | $16.88 | 2024 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.